-
Dorian and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
americanpharmaceuticalreview
May 28, 2021
HitGen announced that it has entered into a research collaboration agreement with Dorian Therapeutics, a private biotechnology company developing senoblockers, a new class of therapeutics that can rejuvenate cells and tissues.
-
HitGen to acquire Vernalis for $25 mn in cash
expresspharma
October 14, 2020
The closing of this transaction is subject to customary conditions and approvals, expected to complete before the end of 2020.
-
Kaken Pharma, HitGen to develop a novel class of drugs
biospectrumasia
April 14, 2019
Under the terms of the collaborative agreement, HitGen will grant exclusive rights to Kaken for further development and commercialization……
-
HitGen and Almirall Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
pharmafocusasia
March 27, 2019
HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded l
-
HitGen, Almirall to identify novel drug targets
biospectrumasia
March 26, 2019
HitGen will receive upfront payments, and be eligible for milestone payments from Almirall
-
SPARC inks research collaboration pact with China’s HitGen
expressbpd
March 14, 2019
Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments
-
SPARC inks research collaboration pact with China’s HitGen
expressbpd
March 13, 2019
Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments
-
HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
pharmafocusasia
March 13, 2019
HitGen Ltd. and Sun Pharma Advanced Research Company Ltd. (SPARC) today announced a research collaboration to identify novel small molecule leads for targets of interest.
-
HitGen and Mitsubishi Tanabe Pharma Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
pharmafocusasia
December 11, 2018
HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation....
-
HitGen, Biogen initiate drug discovery collaboration
pharmatimes
November 26, 2018
HitGen Ltd has announced that the company has entered into a drug discovery research collaboration with Biogen to identify novel small molecule leads for targets of interest.